7000 years ago: One of the oldest cases of tuberculosis discovered

Tuberculosis was present in Europe as early as 7000 years ago, according to new research published October 30th in the open-access journal PLOS ONE, by Muriel Masson and colleagues at the University of Szeged.

A disease called Hypertrophic Pulmonary Osteopathy is characterized by symmetrical new bone formations on the long bones. Based on the archaeological record, it has been suggested that tuberculosis might have caused HPO thousands of years ago. HPO is a rare find in the , making it difficult to verify this hypothesis.

In this study, the authors examined seventy-one human skeletons from a 7000-year-old site in the south of Hungary. They found numerous cases of infections and metabolic diseases, and some skeletons showed signs of HPO and therefore potentially tuberculosis. They focused on one skeleton in particular to verify this hypothesis, and analyzed the ancient DNA and lipids from its bones to do so. Both tests confirmed the presence of the bacterial complex associated with tuberculosis.

This is one of the earliest known cases of HPO and to date, and helps shed new light on this European community in prehistoric times. Masson adds, "This is a crucial find from a fantastic site. It is not only the earliest occurrence of fully-developed HPO on an adult skeleton to date, but also clearly establishes the presence of Tuberculosis in Europe 7000 years ago."

More information: Masson M, Molnár E, Donoghue HD, Besra GS, Minnikin DE, et al. (2013) Osteological and Biomolecular Evidence of a 7000-Year Old Case of Hypertrophic Pulmonary Osteopathy Secondary to Tuberculosis from Neolithic Hungary. PLoS ONE 8(10): e78252. DOI: 10.1371/journal.pone.0078252

add to favorites email to friend print save as pdf

Related Stories

Potential new drug for tuberculosis

Aug 05, 2013

A new drug capable of inhibiting growth of Mycobacterium tuberculosis is reported this week in Nature Medicine. The findings may improve therapeutic options for the treatment of drug resistant tuberculosis (TB). ...

FDA approves first new tuberculosis in 40 years

Dec 31, 2012

The Food and Drug Administration says it has approved a Johnson & Johnson tuberculosis drug that is the first new medicine to fight the deadly infection in more than four decades.

Recommended for you

UN implores all countries to help on Ebola

1 hour ago

The international group Doctor Without Borders warned Tuesday that the world is 'losing the battle' against Ebola, while U.N. officials implored all countries to quickly step up their response by contributing health experts ...

Travel restrictions could worsen Ebola crisis: experts

6 hours ago

Travel restrictions could worsen West Africa's Ebola epidemic, limiting medical and food supplies and keeping out much-needed doctors, virologists said Tuesday as the disease continued its deadly spread.

World 'losing battle' to contain Ebola: MSF (Update)

6 hours ago

International medical agency Medecins sans Frontieres said Tuesday the world was "losing the battle" to contain Ebola as the United Nations warned of severe food shortages in the hardest-hit countries.

Mutating Ebola viruses not as scary as evolving ones

7 hours ago

My social media accounts today are cluttered with stories about "mutating" Ebola viruses. The usually excellent ScienceAlert, for example, rather breathlessly informs us "The Ebola virus is mutating faster in humans than in animal hosts ...

War between bacteria and phages benefits humans

8 hours ago

In the battle between our immune systems and cholera bacteria, humans may have an unknown ally in bacteria-killing viruses known as phages. In a new study, researchers from Tufts University, Massachusetts ...

User comments